SCHEMBL8349353

SCHEMBL8349353

Nc1cccc(Nc2cc(-c3cccc(NC(=O)c4ccco4)c3)ccn2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.71
MAPK10 P53779 1/20 0.71
KDM4E B2RXH2 7/20 0.54
ALDH1A1 P00352 7/20 0.54
MAPT P10636 5/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
HTT P42858 2/20 0.54
MAPK1 P28482 2/20 0.54
JAK2 O60674 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
NPSR1 Q6W5P4 2/20 0.53
TSHR P16473 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
CDC25A P30304 1/20 0.52
DUSP3 P51452 1/20 0.52
USP2 O75604 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351775 0.93 MAPK8 (0.69) MAPK8MAPK10KDM4EALDH1A1MAPT
SCHEMBL4004296 0.88 MAPK8 (0.72) MAPK8MAPK10KDM4EALDH1A1MAPT
SCHEMBL3999434 0.86 MAPK8 (0.66) MAPK8MAPK10KDM4EALDH1A1MAPT
SCHEMBL3996393 0.85 NPC1 (0.70) MAPK8MAPK10KDM4EALDH1A1MAPT
SCHEMBL4002795 0.84 GRM4 (0.53) MAPK8MAPK10JAK2SMN1; SMN2NPC1
SCHEMBL1518754 0.83 MAPK8 (1.00) MAPK8MAPK10KDM4EALDH1A1MAPT
SCHEMBL4003048 0.82 ABL1 (0.60) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL3647264 0.82 ALDH1A1 (0.68) ALDH1A1MAPTMEN1KMT2AHTT
SCHEMBL4001863 0.80 MAPT (0.67) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL3997662 0.76 ABL1 (0.59) MAPK8MEN1KMT2AJAK2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 WO disclosed